About
Financing built on disclosure
We provide margin financing to active traders and professional investors, on terms that can be verified rather than merely accepted.
Our approach
Securities-backed lending has historically been priced at the lender's discretion, with borrowers given a rate and little means of assessing whether it was fair or how it would move. We take the opposite approach: every rate we charge is the sum of an independently published benchmark and a contractual spread that is disclosed in advance.
The same principle applies to risk. Advance rates, concentration treatment, margin call levels and stop-out levels are published rather than buried. A borrower who can model their position under a 30% market decline before drawing is a borrower who will still be solvent after one.
What we do
- Margin financing. Credit facilities secured against eligible listed portfolios, with daily accrual and monthly settlement.
- Multi-currency lending. Facilities in sterling, US dollars and euros, each priced against the relevant published benchmark.
- Portfolio assessment. Detailed collateral review setting out the advance rate applied to each holding, not merely an aggregate limit.
Principles
Published pricing
Benchmark plus spread, with the benchmark verifiable against the administrator's own publication and the spread fixed by contract.
No fee stacking
Interest is the cost of the facility. We do not levy arrangement fees, commitment fees on undrawn balances, or minimum monthly charges. Third-party costs are passed through at cost and itemised.
Risk parameters in the open
Every threshold capable of forcing an action on your account is published on this site and set out in your facility agreement, with the response window stated explicitly.
Suitability before scale
Leverage is not appropriate for every portfolio or every investor. Where a portfolio's composition makes a facility inadvisable, we say so rather than extending a limit that a borrower cannot survive using.
Contact
Email info@sterlingconsortium.co.uk or call+44 7874 485696 to discuss eligibility and indicative pricing.